TAZORAC

Product NDC
0023-9155
11-digit product format
000239155
Labeler code
0023
Product ID
0023-9155_95555a72-13d3-4a9f-ae7e-b1bc680ba214
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
tazarotene
Dosage form
CREAM
Route
CUTANEOUS
Labeler
Allergan, Inc.
Application
NDA021184
Marketing category
NDA
Marketing start
2000-11-15
Marketing end
0000-00-00
Substance
TAZAROTENE
Active strength
1 mg/g
Pharmacologic classes
Retinoid [EPC],Retinoids [CS]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0023-9155-30GM - Gram0023-915582a24ce5-50f4-46fb-8a17-f5d14cc7df2a12012-07-24
0023-9155-60GM - Gram0023-9155a0db15dc-a493-4958-8cf6-b5864a2e7dd212012-07-24

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0023-9155-15000239155151 TUBE in 1 CARTON (0023-9155-15) > 3.5 g in 1 TUBE1 tube2000-11-150000-00-00NoNoCurrent
0023-9155-30000239155301 TUBE in 1 CARTON (0023-9155-30) > 30 g in 1 TUBE1 tube2000-11-150000-00-00NoNoCurrent
0023-9155-60000239155601 TUBE in 1 CARTON (0023-9155-60) > 60 g in 1 TUBE1 tube2000-11-150000-00-00NoNoCurrent